Sanofi Tells Justices To Pass On Appeal Over Repatha IP
Sanofi-Aventis has urged the U.S. Supreme Court not to hear an appeal by Amgen Inc. of a Federal Circuit decision that revived a challenge to Amgen's patents for its cholesterol drug...To view the full article, register now.
Already a subscriber? Click here to view full article